These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Kinlay S, Schwartz GG, Olsson AG, Rifai N, Sasiela WJ, Szarek M, Ganz P, Libby P, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Circulation; 2004 Jul 27; 110(4):386-91. PubMed ID: 15262833 [Abstract] [Full Text] [Related]
5. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study. Alber HF, Frick M, Suessenbacher A, Doerler J, Schirmer M, Stocker EM, Dichtl W, Pachinger O, Weidinger F. Am Heart J; 2006 Jan 27; 151(1):139. PubMed ID: 16368305 [Abstract] [Full Text] [Related]
6. Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cytometry. Labiós M, Martínez M, Gabriel F, Guiral V, Martínez E, Aznar J. Thromb Res; 2005 Jan 27; 115(4):263-70. PubMed ID: 15668185 [Abstract] [Full Text] [Related]
7. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects. Puccetti L, Bruni F, Bova G, Cercignani M, Palazzuoli A, Console E, Auteri A, Pasqui AL. Nutr Metab Cardiovasc Dis; 2001 Dec 27; 11(6):378-87. PubMed ID: 12055702 [Abstract] [Full Text] [Related]
8. Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin. Pignatelli P, Sanguigni V, Lenti L, Loffredo L, Carnevale R, Sorge R, Violi F. J Thromb Haemost; 2007 Jun 27; 5(6):1170-8. PubMed ID: 17388962 [Abstract] [Full Text] [Related]
9. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes. Mitsios JV, Papathanasiou AI, Elisaf M, Goudevenos JA, Tselepis AD. Platelets; 2005 Aug 27; 16(5):287-92. PubMed ID: 16011979 [Abstract] [Full Text] [Related]
10. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets? Piorkowski M, Fischer S, Stellbaum C, Jaster M, Martus P, Morguet AJ, Schultheiss HP, Rauch U. J Am Coll Cardiol; 2007 Mar 13; 49(10):1035-42. PubMed ID: 17349882 [Abstract] [Full Text] [Related]
11. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention. Lim HS, Blann AD, Lip GY. Circulation; 2004 Jun 01; 109(21):2524-8. PubMed ID: 15136493 [Abstract] [Full Text] [Related]
12. Effect of atorvastatin on the expression of CD40 ligand and P-selectin on platelets in patients with hypercholesterolemia. Hwang YS, Tsai WC, Lu YH, Lin CC, Chen YF. Am J Cardiol; 2004 Aug 01; 94(3):364-6. PubMed ID: 15276107 [Abstract] [Full Text] [Related]
13. Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects. Bruni F, Pasqui AL, Pastorelli M, Bova G, Di Renzo M, Cercigani M, Leo A, Auteri A, Puccetti L. Int J Cardiol; 2004 Jun 01; 95(2-3):269-74. PubMed ID: 15193831 [Abstract] [Full Text] [Related]
14. The effect of a platelet cholesterol modulation on the acetylsalicylic acid-mediated blood platelet inhibition in hypercholesterolemic patients. Luzak B, Boncler M, Rywaniak J, Wilk R, Stanczyk L, Czyz M, Rysz J, Watala C. Eur J Pharmacol; 2011 May 11; 658(2-3):91-7. PubMed ID: 21371451 [Abstract] [Full Text] [Related]
15. Atorvastatin reduces thrombin generation after percutaneous coronary intervention independent of soluble tissue factor. Bartok A, Steiner S, Seidinger D, Jetzl A, Huber K, Minar E, Stefenelli T, Kopp CW. Thromb Res; 2005 May 11; 115(6):469-74. PubMed ID: 15792677 [Abstract] [Full Text] [Related]
16. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia. Joukhadar C, Klein N, Prinz M, Schrolnberger C, Vukovich T, Wolzt M, Schmetterer L, Dorner GT. Thromb Haemost; 2001 Jan 11; 85(1):47-51. PubMed ID: 11204586 [Abstract] [Full Text] [Related]
17. Increased superoxide anion production by platelets in hypercholesterolemic patients. Sanguigni V, Pignatelli P, Caccese D, Pulcinelli FM, Lenti L, Magnaterra R, Martini F, Lauro R, Violi F. Thromb Haemost; 2002 May 11; 87(5):796-801. PubMed ID: 12038779 [Abstract] [Full Text] [Related]
18. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study. Tetik S, Ak K, Isbir S, Eksioglu-Demiralp E, Arsan S, Iqbal O, Yardimci T. Clin Appl Thromb Hemost; 2010 Apr 11; 16(2):189-98. PubMed ID: 19703819 [Abstract] [Full Text] [Related]